The world is depending on vaccines from companies like Pfizer and Moderna to control the outbreak
Dear Balbir Singh,
After being an almost-invisible protective medical intervention for decades, vaccines are making headlines over the past few weeks. First, it was New York-based Pfizer, which announced that its vaccine against Covid-19 infection was found to be 90% effective. This was followed by Russia’s Gamaleya Research and Moderna claiming 92% and 94.5% effectiveness, respectively. While every positive announcement is greeted with optimism, the challenges associated with vaccines are often forgotten. The first story in today’s edition traces the entire journey of Covid-19 vaccines, told in easy-to-read charts.

PHARMA
Can Moderna, Pfizer vaccines help rein in the contagion?

At the last count, over 200 vaccine projects are reported in various stages of research, all aimed at curbing the spread of the Covid-19 virus. However, there are way too many of them to track. The world is depending on vaccines from companies like Pfizer and Moderna to control the outbreak, but will it be a smooth race?

INFRA
Godrej Properties: debt pain vs. margin gain

Unlike many of its peers, Godrej Properties has managed to achieve a wide footprint in India without stressing its balance sheet. But after its second-quarter earnings, the stock tumbled on worries of rising debt levels. The company’s profitability may improve as it starts monetising assets bought via the upfront land-acquisition model. But that again depends on a few important factors.

TECH
How AI can democratise education

Neural network-based artificial intelligence can now uncover patterns in students’ performance and help teachers optimise strategies accordingly. AI tutors, with which students can interact online, can give them the individualised attention they need. These advances, together with widespread Internet use, can transform education. Here’s how.

Regards,
ET Prime Team